Date
7–8 February 2026
"From Stem Cells to Systems: Advancing Science, Transforming Care"
New Approaches to Blood Stem Cell Generation from Pluripotent Cells
Dr. Anna Bigas
Modulation of bone marrow haematopoietic stem cell activity as a therapeutic strategy after myocardial infarction
Prof. Nina Cabezas-Wallscheid
Incorporating novel conditioning regimen in allogeneic stem cell transplants: the American Hospital of Dubai experience
Dr. Emmanouil Nikolousis
iPS cell based therapy for muscular disorders
Prof. Hidetoshi Sakurai
hiPSCs Cardiac Organoids for Reducing Acute Myocardial Infarction
Dr. Sarkawt Hamad
Prof. Hongkui Deng
Building the Future of Eye Regeneration with iPSCs and Bioprinting
Dr. Heli Skottman
Modeling Monogenic Diabetes Mechanisms Using iPSC-Derived Islets
Dr. Essam Abdelalim
The Saudi Bank of Induced Pluripotent Stem Cells (SBiPSCs)
Dr. Khaled Alsayegh
Introduction remarks German Stem Cell Network
Dr. Daniel Besser
Infection, Innate immunity and cancer in the gut - Organoids as model
Dr. Sina Bartfeld
Malignant stem cells
Prof. Andreas Trumpp
Cell based therapy against liver diseases
Prof. Ludovic Vallier
UCB-MSCs tissue engineering and cardiac repair
Prof. Antoni Bayes Genis
DHA Standards for Stem Cell Services
Dr. Khulood Mohamed Alsayegh
From Bench to Policy: Navigating Regulation
Dr. Haythem Bin Hashr
Production of Clinical Grade MSCs
Prof. Dr. Emad Mahmoud Ibrahim Elzayat
Cord Blood Banking and Clinical Application
Dr. Ayman Hendy
How Transcription Factors Control Stem Cells
Prof. Ralf Jauch
Organoid Applications to Address Unmet Clinical Need
Dr. Vincent Knight-Schrijver
GMP-Manufacturing of Advanced Cell Therapies
Dr. Clemens Dannheim
Cell Manufacturing and Quality Control
Dr. Ulf Gunnar Meißner
Automation in iPSC Cell Line Development
Dr. Riikka Martikainen
Epigenetic Reprogramming with Physical Energies
Prof. Margherita Maioli
Engineering iPSC-based Vascular Organoids
Prof. Mingxia Gu